Placebo + SIM
Phase 2Terminated 0 watching 0 views this week⚡ Active
51
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Liver Fibrosis Due to NASH
Conditions
Liver Fibrosis Due to NASH
Trial Timeline
Oct 29, 2012 → Jan 3, 2017
NCT ID
NCT01672879About Placebo + SIM
Placebo + SIM is a phase 2 stage product being developed by Gilead Sciences for Liver Fibrosis Due to NASH. The current trial status is terminated. This product is registered under clinical trial identifier NCT01672879. Target conditions include Liver Fibrosis Due to NASH.
Hype Score Breakdown
Clinical
17
Activity
12
Company
9
Novelty
5
Community
5
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01672866 | Phase 2 | Terminated |
| NCT01672879 | Phase 2 | Terminated |
Competing Products
20 competing products in Liver Fibrosis Due to NASH